Dual bronchodilation in COPD: lung function and patient-reported outcomes – a review


Several fixed-dose combinations (FDCs) of long-acting bronchodilators (a long-acting muscarinic antagonist [LAMA] plus a long-acting β2-agonist [LABA]) are available for the treatment of COPD. Studies of these FDCs have demonstrated substantial improvements in lung function (forced expiratory volume in 1 second) in comparison with their respective… (More)
DOI: 10.2147/COPD.S116719


12 Figures and Tables

Slides referencing similar topics